PetVivo Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $1.93
- Today's High:
- $1.98
- Open Price:
- $1.95
- 52W Low:
- $1.66
- 52W High:
- $3.6
- Prev. Close:
- $1.95
- Volume:
- 7966
Company Statistics
- Market Cap.:
- $25.60 million
- Book Value:
- 0.034
- Revenue TTM:
- $976171
- Operating Margin TTM:
- -989.68%
- Gross Profit TTM:
- $-85568
- Profit Margin:
- 0%
- Return on Assets TTM:
- -136.88%
- Return on Equity TTM:
- -414.8%
Company Profile
PetVivo Holdings Inc had its IPO on 2013-05-23 under the ticker symbol PETV.
The company operates in the Healthcare sector and Medical Devices industry. PetVivo Holdings Inc has a staff strength of 25 employees.
Stock update
Shares of PetVivo Holdings Inc opened at $1.95 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.93 - $1.98, and closed at $1.93.
This is a -1.03% slip from the previous day's closing price.
A total volume of 7,966 shares were traded at the close of the day’s session.
In the last one week, shares of PetVivo Holdings Inc have increased by +0.52%.
PetVivo Holdings Inc's Key Ratios
PetVivo Holdings Inc has a market cap of $25.60 million, indicating a price to book ratio of 8.1916 and a price to sales ratio of 58.5547.
In the last 12-months PetVivo Holdings Inc’s revenue was $976171 with a gross profit of $-85568 and an EBITDA of $-9542906. The EBITDA ratio measures PetVivo Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, PetVivo Holdings Inc’s operating margin was -989.68% while its return on assets stood at -136.88% with a return of equity of -414.8%.
In Q2, PetVivo Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 101.4%.
PetVivo Holdings Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.85 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PetVivo Holdings Inc’s profitability.
PetVivo Holdings Inc stock is trading at a EV to sales ratio of 48.8796 and a EV to EBITDA ratio of -2.5431. Its price to sales ratio in the trailing 12-months stood at 58.5547.
PetVivo Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.10 million
- Total Liabilities
- $1.46 million
- Operating Cash Flow
- $-47394.00
- Capital Expenditure
- $47394
- Dividend Payout Ratio
- 0%
PetVivo Holdings Inc ended 2024 with $3.10 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.10 million while shareholder equity stood at $398239.00.
PetVivo Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $1.46 million in other current liabilities, 11831.00 in common stock, $-74737606.00 in retained earnings and $0 in goodwill. Its cash balance stood at $218978.00 and cash and short-term investments were $218978.00. The company’s total short-term debt was $159,248 while long-term debt stood at $18650.00.
PetVivo Holdings Inc’s total current assets stands at $1.02 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $47108.00 compared to accounts payable of $591923.00 and inventory worth $406030.00.
In 2024, PetVivo Holdings Inc's operating cash flow was $-47394.00 while its capital expenditure stood at $47394.
Comparatively, PetVivo Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $1.93
- 52-Week High
- $3.6
- 52-Week Low
- $1.66
- Analyst Target Price
- $7
PetVivo Holdings Inc stock is currently trading at $1.93 per share. It touched a 52-week high of $3.6 and a 52-week low of $3.6. Analysts tracking the stock have a 12-month average target price of $7.
Its 50-day moving average was $2.02 and 200-day moving average was $2.38 The short ratio stood at 7.35 indicating a short percent outstanding of 0%.
Around 3315% of the company’s stock are held by insiders while 380.1% are held by institutions.
Frequently Asked Questions About PetVivo Holdings Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.